{"id":"W4399395212","doi":"10.1200/jco.24.00720","title":"Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein–Overexpressing Advanced Nonsquamous <i>EGFR</i> -Wildtype Non–Small Cell Lung Cancer in the Phase II LUMINOSITY Trial","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Hôpital Charles-Le Moyne","funders":"Aptitude Health","keywords":"Medicine; Internal medicine; Oncology; Clinical endpoint; Population; Lung cancer; Phases of clinical research; non-small cell lung cancer (NSCLC); Chemotherapy; Gastroenterology; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007306053,0.0004506464,0.000815423,0.000146816,0.0001731184,0.0005737063,0.0002652945,0.0004150914,0.001440753],"category_scores_gemma":[0.0003571511,0.0002037453,0.0005887196,0.0001363701,0.0002932769,0.0004001275,0.0001605007,0.0009319289,0.0002977052],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004898931,"about_ca_system_score_gemma":0.000484942,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003382388,"about_ca_topic_score_gemma":0.001658709,"domain_scores_codex":[0.9998313,0.00007289329,0.000009925523,0.00002746435,0.00001830861,0.00004009607],"domain_scores_gemma":[0.9998324,0.000031368,0.0000347869,0.000008579986,0.000009639149,0.00008317002],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6711729,0.01730809,0.03814588,0.001609304,0.001941993,0.0004213602,0.0004440098,0.003271459,0.06790862,0.0006425497,0.005604741,0.1915291],"study_design_scores_gemma":[0.4721146,0.4253182,0.08188824,0.0001882348,0.001152089,0.0006519257,0.0001574743,0.003394647,0.005539107,0.0003574681,0.009191141,0.00004693348],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9942545,0.002821302,0.0001990156,0.0001515753,0.00006391678,0.0005658635,0.0002229209,0.00002743226,0.001693479],"genre_scores_gemma":[0.9961578,0.001196916,0.0002742229,0.0003271032,0.00007214914,0.0004490884,0.0005935791,0.000006274834,0.0009228605],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001440753,"threshold_uncertainty_score":0.00481981,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03374558598530639,"score_gpt":0.442970732632129,"score_spread":0.4092251466468226,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}